nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfacetamide—Secondary infection—Tretinoin—peripheral nervous system neoplasm	0.0668	0.068	CcSEcCtD
Sulfacetamide—Secondary infection—Isotretinoin—peripheral nervous system neoplasm	0.0668	0.068	CcSEcCtD
Sulfacetamide—Secondary infection—Alitretinoin—peripheral nervous system neoplasm	0.0506	0.0515	CcSEcCtD
Sulfacetamide—Blister—Tretinoin—peripheral nervous system neoplasm	0.0272	0.0277	CcSEcCtD
Sulfacetamide—Blister—Isotretinoin—peripheral nervous system neoplasm	0.0272	0.0277	CcSEcCtD
Sulfacetamide—Stinging—Tretinoin—peripheral nervous system neoplasm	0.0242	0.0247	CcSEcCtD
Sulfacetamide—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.0242	0.0247	CcSEcCtD
Sulfacetamide—Secondary infection—Epirubicin—peripheral nervous system neoplasm	0.0222	0.0225	CcSEcCtD
Sulfacetamide—Blister—Alitretinoin—peripheral nervous system neoplasm	0.0206	0.021	CcSEcCtD
Sulfacetamide—Secondary infection—Doxorubicin—peripheral nervous system neoplasm	0.0205	0.0209	CcSEcCtD
Sulfacetamide—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.0184	0.0187	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.0151	0.0153	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Topotecan—peripheral nervous system neoplasm	0.015	0.0153	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Isotretinoin—peripheral nervous system neoplasm	0.0149	0.0152	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Tretinoin—peripheral nervous system neoplasm	0.0149	0.0152	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Tretinoin—peripheral nervous system neoplasm	0.0128	0.0131	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Isotretinoin—peripheral nervous system neoplasm	0.0128	0.0131	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Alitretinoin—peripheral nervous system neoplasm	0.0113	0.0115	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Tretinoin—peripheral nervous system neoplasm	0.0109	0.0111	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Isotretinoin—peripheral nervous system neoplasm	0.0109	0.0111	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Dactinomycin—peripheral nervous system neoplasm	0.0105	0.0107	CcSEcCtD
Sulfacetamide—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0104	CcSEcCtD
Sulfacetamide—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.0103	0.0104	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Alitretinoin—peripheral nervous system neoplasm	0.00973	0.0099	CcSEcCtD
Sulfacetamide—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.00932	0.00949	CcSEcCtD
Sulfacetamide—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.00932	0.00949	CcSEcCtD
Sulfacetamide—Blister—Epirubicin—peripheral nervous system neoplasm	0.00904	0.00919	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.0089	0.00906	CcSEcCtD
Sulfacetamide—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00859	0.00873	CcSEcCtD
Sulfacetamide—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00859	0.00873	CcSEcCtD
Sulfacetamide—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00838	0.00852	CcSEcCtD
Sulfacetamide—Blister—Doxorubicin—peripheral nervous system neoplasm	0.00836	0.0085	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00825	0.0084	CcSEcCtD
Sulfacetamide—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00804	0.00818	CcSEcCtD
Sulfacetamide—Blood disorder—Epirubicin—peripheral nervous system neoplasm	0.0078	0.00793	CcSEcCtD
Sulfacetamide—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00777	0.0079	CcSEcCtD
Sulfacetamide—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00762	0.00775	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.00759	0.00773	CcSEcCtD
Sulfacetamide—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00744	0.00757	CcSEcCtD
Sulfacetamide—Blood disorder—Doxorubicin—peripheral nervous system neoplasm	0.00721	0.00734	CcSEcCtD
Sulfacetamide—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00707	0.00719	CcSEcCtD
Sulfacetamide—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00702	0.00714	CcSEcCtD
Sulfacetamide—Infection—Topotecan—peripheral nervous system neoplasm	0.00702	0.00714	CcSEcCtD
Sulfacetamide—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00701	0.00713	CcSEcCtD
Sulfacetamide—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00701	0.00713	CcSEcCtD
Sulfacetamide—Infection—Tretinoin—peripheral nervous system neoplasm	0.00696	0.00708	CcSEcCtD
Sulfacetamide—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00696	0.00708	CcSEcCtD
Sulfacetamide—Oedema—Melphalan—peripheral nervous system neoplasm	0.00692	0.00704	CcSEcCtD
Sulfacetamide—Infection—Melphalan—peripheral nervous system neoplasm	0.00687	0.00699	CcSEcCtD
Sulfacetamide—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00651	0.00662	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00644	0.00655	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00611	0.00622	CcSEcCtD
Sulfacetamide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00606	0.00617	CcSEcCtD
Sulfacetamide—Pain—Topotecan—peripheral nervous system neoplasm	0.00604	0.00614	CcSEcCtD
Sulfacetamide—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00599	0.0061	CcSEcCtD
Sulfacetamide—Pain—Tretinoin—peripheral nervous system neoplasm	0.00599	0.0061	CcSEcCtD
Sulfacetamide—Pain—Melphalan—peripheral nervous system neoplasm	0.00591	0.00602	CcSEcCtD
Sulfacetamide—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00573	0.00583	CcSEcCtD
Sulfacetamide—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00569	0.00579	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00566	0.00576	CcSEcCtD
Sulfacetamide—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00554	0.00564	CcSEcCtD
Sulfacetamide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00552	0.00561	CcSEcCtD
Sulfacetamide—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00531	0.0054	CcSEcCtD
Sulfacetamide—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00528	0.00537	CcSEcCtD
Sulfacetamide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0052	0.00529	CcSEcCtD
Sulfacetamide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00516	0.00525	CcSEcCtD
Sulfacetamide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00516	0.00525	CcSEcCtD
Sulfacetamide—Oedema—Vincristine—peripheral nervous system neoplasm	0.00512	0.00521	CcSEcCtD
Sulfacetamide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0051	0.00518	CcSEcCtD
Sulfacetamide—Infection—Vincristine—peripheral nervous system neoplasm	0.00508	0.00517	CcSEcCtD
Sulfacetamide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.005	0.00508	CcSEcCtD
Sulfacetamide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00496	0.00504	CcSEcCtD
Sulfacetamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00496	0.00504	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.00495	0.00503	CcSEcCtD
Sulfacetamide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.0049	0.00498	CcSEcCtD
Sulfacetamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00489	0.00498	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.00458	0.00466	CcSEcCtD
Sulfacetamide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00454	0.00462	CcSEcCtD
Sulfacetamide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00452	0.0046	CcSEcCtD
Sulfacetamide—Infection—Cisplatin—peripheral nervous system neoplasm	0.00449	0.00457	CcSEcCtD
Sulfacetamide—Procainamide—BCHE—peripheral nervous system neoplasm	0.00442	0.26	CrCbGaD
Sulfacetamide—Pain—Vincristine—peripheral nervous system neoplasm	0.00438	0.00445	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00426	0.00433	CcSEcCtD
Sulfacetamide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00422	0.00429	CcSEcCtD
Sulfacetamide—Infection—Etoposide—peripheral nervous system neoplasm	0.00412	0.00419	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00394	0.00401	CcSEcCtD
Sulfacetamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00391	0.00398	CcSEcCtD
Sulfacetamide—Pain—Cisplatin—peripheral nervous system neoplasm	0.00387	0.00394	CcSEcCtD
Sulfacetamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00377	0.00383	CcSEcCtD
Sulfacetamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00376	0.00382	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00361	0.00367	CcSEcCtD
Sulfacetamide—Pain—Etoposide—peripheral nervous system neoplasm	0.00354	0.00361	CcSEcCtD
Sulfacetamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.0034	0.00346	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00334	0.0034	CcSEcCtD
Sulfacetamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00333	0.00339	CcSEcCtD
Sulfacetamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00315	0.0032	CcSEcCtD
Sulfacetamide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00309	0.00315	CcSEcCtD
Sulfacetamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00305	0.00311	CcSEcCtD
Sulfacetamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00293	0.00298	CcSEcCtD
Sulfacetamide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00286	0.00291	CcSEcCtD
Sulfacetamide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00285	0.0029	CcSEcCtD
Sulfacetamide—Chlorpropamide—ABCB1—peripheral nervous system neoplasm	0.00273	0.161	CrCbGaD
Sulfacetamide—Acetaminophen—ABCB1—peripheral nervous system neoplasm	0.0027	0.159	CrCbGaD
Sulfacetamide—Benzocaine—ABCB1—peripheral nervous system neoplasm	0.00266	0.156	CrCbGaD
Sulfacetamide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00263	0.00268	CcSEcCtD
Sulfacetamide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00232	0.00236	CcSEcCtD
Sulfacetamide—Infection—Epirubicin—peripheral nervous system neoplasm	0.00231	0.00235	CcSEcCtD
Sulfacetamide—Probenecid—ABCB1—peripheral nervous system neoplasm	0.00225	0.133	CrCbGaD
Sulfacetamide—Aminohippurate—ABCB1—peripheral nervous system neoplasm	0.00222	0.131	CrCbGaD
Sulfacetamide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00215	0.00219	CcSEcCtD
Sulfacetamide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00214	0.00217	CcSEcCtD
Sulfacetamide—Pain—Epirubicin—peripheral nervous system neoplasm	0.00199	0.00202	CcSEcCtD
Sulfacetamide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Sulfacetamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00171	0.00174	CcSEcCtD
Sulfacetamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00167	CcSEcCtD
Sulfacetamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00161	CcSEcCtD
Sulfacetamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00155	CcSEcCtD
